Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Non-randomized Study to Evaluate the Safety and Efficacy of Left Gastric Artery Embolization in Obese Patients With Hepatocellular Carcinoma to Achieve Appropriate Weight Loss That May Allow Them to be Transplanted

NCT02935478 is registered in ClinicalTrials.gov with St. Louis University as lead sponsor.

NCT NCT02935478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02935478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Non-randomized Study to Evaluate the Safety and Efficacy of Left Gastric Artery Embolization in Obese Patients With Hepatocellular Carcinoma to Achieve Appropriate Weight Loss That May Allow Them to be Transplanted
Lead sponsor
St. Louis University
Phase
Not applicable
Overall status
Suspended
Start date
October 18, 2017
Completion date
December 31, 2027
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

body weight, cirrhosis, hcc, hepatitis c, hepatocellular carcinoma, obesity, weight loss